🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study intends to evaluate the following objectives in patients with adv...
Status
Terminated
Location
Multiple Locations
Start Date
2016-12-13
Trial ID
NCT02992340
Treatments Being Tested
This study is designed to study the efficacy of ASLAN 001 plus capecitabine...
Status
Terminated
Location
National Cancer Centre Singapore
Start Date
2016-08-11
Trial ID
NCT07166367
Treatments Being Tested
This is a single-centre, open-label, non-randomised, single oral dose study...
Status
Completed
Location
Quotient Clinical Ltd
Start Date
2017-11-23
Trial ID
NCT03368846
Treatments Being Tested
This protocol for Varlitinib is developed for the treatment of Biliary Trac...
Status
Completed
Location
No.81 Hospital of The Chinese People's Liberation Army
Start Date
2017-12-19
Trial ID
NCT03231176
Treatments Being Tested
The purpose of this study is to explore safety and efficacy of varlitinib a...
Status
Completed
Location
ASLAN Selected sites
Start Date
2017-01-31
Trial ID
NCT03082053
Treatments Being Tested
This protocol for Varlitinib is developed for the treatment of Biliary Trac...
Status
Completed
Location
Banner MD Anderson Cancer Center
Start Date
2017-07-04
Trial ID
NCT03093870
Treatments Being Tested
The purpose of the study is to assess the efficacy of varlitinib in combina...
Status
Withdrawn
Location
Multiple Locations
Start Date
2018-05
Trial ID
NCT03129074
Treatments Being Tested
This is a phase IB study to assess the safety and tolerability of ASLAN001 ...
Status
Completed
Location
Queen Mary Hospital
Start Date
2014-08-05
Trial ID
NCT02648425
Treatments Being Tested
This protocol for Varlitinib is developed for the treatment of Gastric Canc...
Status
Completed
Location
2 Sites
Start Date
2017-08-31
Trial ID
NCT03130790
Treatments Being Tested
This is a single arm, multicentre, Phase 2 study to assess efficacy and saf...
Status
Completed
Location
Multiple Locations
Start Date
2015-11-16
Trial ID
NCT02609958
Treatments Being Tested